Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
VanEck Biotech ETF
BBH
$424M
| $4.96M | ﹤0.01% |
38,336
-8,728
| -19% | -$1.08M |
|
2927
Protagonist Therapeutics
PTGX
$10B
| $4.96M | ﹤0.01% |
409,847
+46,120
| +13% | +$510K |
|
|
WPX
2928
CALL
DELISTED
WPX Energy, Inc.
WPX
| $4.96M | ﹤0.01% |
431,000
+268,700
| +166% | +$3.34M |
|
2929
CALL
Children's Place
PLCE
$54.3M
| $4.96M | ﹤0.01% |
52,000
+1,600
| +3% | +$163K |
|
2930
Tencent Music
TME
$14.5B
| $4.96M | ﹤0.01% |
+330,632
| New | +$5.22M |
|
2931
CALL
TTEC Holdings
TTEC
$77.9M
| $4.95M | ﹤0.01% |
106,300
-2,400
| -2% | -$92.6K |
|
|
CMRX
2932
DELISTED
Chimerix, Inc.
CMRX
| $4.95M | ﹤0.01% |
1,146,390
+1,046,575
| +1,049% | +$3.22M |
|
2933
PUT
Prospect Capital
PSEC
$1.15B
| $4.95M | ﹤0.01% |
757,900
-63,300
| -8% | -$419K |
|
2934
Myriad Genetics
MYGN
$290M
| $4.95M | ﹤0.01% |
178,091
-58,158
| -25% | -$1.64M |
|
2935
State Street SPDR S&P Insurance ETF
KIE
$684M
| $4.94M | ﹤0.01% |
145,431
+24,279
| +20% | +$799K |
|
|
2936
PUT
Tencent Music
TME
$14.5B
| $4.94M | ﹤0.01% |
329,700
+148,100
| +82% | +$2.34M |
|
2937
PUT
Willis Towers Watson
WTW
$30.8B
| $4.94M | ﹤0.01% |
25,800
+3,700
| +17% | +$670K |
|
2938
Rambus
RMBS
$10.9B
| $4.93M | ﹤0.01% |
409,631
-215,143
| -34% | -$2.46M |
|
|
THS
2939
CALL
DELISTED
Treehouse Foods
THS
| $4.93M | ﹤0.01% |
91,100
+25,300
| +38% | +$1.48M |
|
2940
HEICO Corp
HEI
$52.4B
| $4.93M | ﹤0.01% |
+36,812
| New | +$4.09M |
|
2941
Lear
LEA
$8.32B
| $4.92M | ﹤0.01% |
35,356
-31,103
| -47% | -$4.36M |
|
2942
Watts Water Technologies
WTS
$12.8B
| $4.92M | ﹤0.01% |
52,842
+9,911
| +23% | +$846K |
|
2943
CALL
Enbridge
ENB
$111B
| $4.92M | ﹤0.01% |
136,300
+37,800
| +38% | +$1.38M |
|
2944
RPC Inc
RES
$1.41B
| $4.92M | ﹤0.01% |
681,903
+264,170
| +63% | +$2.51M |
|
|
MDC
2945
DELISTED
M.D.C. Holdings, Inc.
MDC
| $4.91M | ﹤0.01% |
161,703
-98,642
| -38% | -$2.9M |
|
2946
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
| $4.91M | ﹤0.01% |
4,888
+4,704
| +2,557% | +$4.56M |
|
2947
Penske Automotive Group
PAG
$14.4B
| $4.9M | ﹤0.01% |
103,623
-9,183
| -8% | -$417K |
|
|
CJ
2948
DELISTED
C&J Energy Services, Inc.
CJ
| $4.9M | ﹤0.01% |
416,026
-74,352
| -15% | -$1.02M |
|
2949
Talos Energy
TALO
$2.63B
| $4.9M | ﹤0.01% |
203,633
+92,322
| +83% | +$2.41M |
|
2950
PUT
Enphase Energy
ENPH
$5.35B
| $4.9M | ﹤0.01% |
+268,600
| New | +$3.7M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.